| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8794180 | Ophthalmology | 2018 | 12 Pages |
Abstract
By 12 months, the risk of exudation was greater for eyes with documented subclinical MNV compared with eyes without detectable MNV. For eyes with subclinical MNV, recommendations include more frequent follow-up and home monitoring. Intravitreal therapy is not recommended until prospective studies are performed.
Keywords
AMDORCCRPESHRMCATTComparison of Age-related Macular Degeneration Treatment TrialsICGAMNVOCTAgeographic atrophyOCT angiographyIndocyanine green angiographyretinal pigment epitheliumswept-sourcespectral-domainage-related macular degenerationVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)AnchorMarinasubretinal hyperreflective material
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
João R. MD, PhD, Qinqin PhD, José M.B. MD, Fang MD, Elie H. MD, PhD, Luiz MD, PhD, Andrew MD, Chieh-Li PhD, Sophie MS, Luis PhD, Mary K. PhD, William MS, Ruikang K. PhD, Giovanni PhD, Philip J. MD, PhD,